Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.74 USD | +2.33% | -1.09% | -40.88% |
29/04 | Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating | MT |
26/04 | UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.88% | 211.14Cr | |
+54.38% | 276.86Cr | |
+115.18% | 70Cr | |
+12.20% | 48Cr | |
-66.59% | 15Cr | |
-46.04% | 6.68Cr |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- Teladoc's Q4 Net Loss Narrows as Revenue Increases; Issues Q1, 2024 Guidance